Big Screen Entertainment Group Advances Film Pipeline, Led by $30 Million Epic "Dream of Love"
https://www.otcmarkets.com/news-otcapi/news/d...d?id=92640
From releasing Hollywood films in 5,000+ China theaters to importing China's epics — BSEG and HiFex pipeline now runs both ways
BEVERLY HILLS, Calif., August 24, 2026 (OTC: BSEG) — Big Screen Entertainment Group today announced major progress across its international film pipeline, content portfolio, and beauty technology division — the opening moves in the most ambitious phase in the company's history.
Built on more than two decades of relationships, IP, and hard-won operating experience, BSEG is now converting those assets into scalable businesses. At the center: a bi-directional distribution pipeline with China and the advancement of Dream of Love, a roughly $30 million epic feature.
Dream of Love, directed by Hu Mei and adapted from Cao Xueqin's classic novel The Dream of the Red Chamber, was nominated for Best Picture and won Best Supporting Actress and a Special Jury Award at the Golden Crane Awards. Final deliverables and distribution scheduling are underway.
"Dream of Love is exactly the kind of film we set out to bring to the world — a beautiful, large-scale story that resonates across cultures," said Kimberley Kates, CEO of BSEG. "Moving films like this between China and the rest of the world is what makes our pipeline one of a kind."
According to Jimmy Jiang, CEO of Hollywood International Film Exchange (HiFex), the film is targeting a Fall 2026 release across major streaming platforms, with special theatrical screenings in cities with large Chinese populations.
A Bi-Directional China Pipeline
Through its long-standing partnership with Hollywood International Film Exchange, BSEG and HiFex have released major motion pictures into the Chinese market — including Papillon and the most recent Death Wish — across more than 5,000 theaters and over 10,000 screens. Very few companies of BSEG's size have ever achieved theatrical distribution at this scale in China.
That relationship now runs in both directions. BSEG/HiFex are receiving epic films from China for international release, including a completed 60-episode television series on the life of Kublai Khan, now being prepared for markets outside China.
Content and Distribution
BSEG continues to develop, acquire, and distribute projects across film, television, streaming, and audio. Current projects include Hollywood Legends: Marilyn Monroe, Silver Screen Beauties, and Avenger Field, an original audio production for Audible.
Beauty Technology
BSEG's second platform is beauty technology. CEO Kimberley Kates and Director and CTO Dr. Bruce B. Lee have developed the company's first patent-pending beauty device — an advanced regenerative skincare device paired with a proprietary formula for the face and body. Dr. Lee previously created Acessa, acquired by Hologic for approximately $80 million in cash plus contingent payments.
BSEG is evaluating manufacturing, branding, licensing, and distribution, including a direct-to-consumer channel.
"This device represents years of work at the intersection of technology and regenerative skincare," said Dr. Bruce B. Lee. "We've combined an advanced device with a proprietary formula to deliver meaningful, visible results — with significant potential in the consumer market."
Strategic Combinations
Over the past year, BSEG has held discussions with multiple parties regarding potential mergers, strategic combinations, and other corporate transactions. Several continue under non-disclosure agreements.
"We built these relationships over twenty years, one film and one partner at a time," said Kates. "Now they are starting to compound — and we intend to make the most of every one of them."
https://www.otcmarkets.com/news-otcapi/news/d...d?id=92640
From releasing Hollywood films in 5,000+ China theaters to importing China's epics — BSEG and HiFex pipeline now runs both ways
BEVERLY HILLS, Calif., August 24, 2026 (OTC: BSEG) — Big Screen Entertainment Group today announced major progress across its international film pipeline, content portfolio, and beauty technology division — the opening moves in the most ambitious phase in the company's history.
Built on more than two decades of relationships, IP, and hard-won operating experience, BSEG is now converting those assets into scalable businesses. At the center: a bi-directional distribution pipeline with China and the advancement of Dream of Love, a roughly $30 million epic feature.
Dream of Love, directed by Hu Mei and adapted from Cao Xueqin's classic novel The Dream of the Red Chamber, was nominated for Best Picture and won Best Supporting Actress and a Special Jury Award at the Golden Crane Awards. Final deliverables and distribution scheduling are underway.
"Dream of Love is exactly the kind of film we set out to bring to the world — a beautiful, large-scale story that resonates across cultures," said Kimberley Kates, CEO of BSEG. "Moving films like this between China and the rest of the world is what makes our pipeline one of a kind."
According to Jimmy Jiang, CEO of Hollywood International Film Exchange (HiFex), the film is targeting a Fall 2026 release across major streaming platforms, with special theatrical screenings in cities with large Chinese populations.
A Bi-Directional China Pipeline
Through its long-standing partnership with Hollywood International Film Exchange, BSEG and HiFex have released major motion pictures into the Chinese market — including Papillon and the most recent Death Wish — across more than 5,000 theaters and over 10,000 screens. Very few companies of BSEG's size have ever achieved theatrical distribution at this scale in China.
That relationship now runs in both directions. BSEG/HiFex are receiving epic films from China for international release, including a completed 60-episode television series on the life of Kublai Khan, now being prepared for markets outside China.
Content and Distribution
BSEG continues to develop, acquire, and distribute projects across film, television, streaming, and audio. Current projects include Hollywood Legends: Marilyn Monroe, Silver Screen Beauties, and Avenger Field, an original audio production for Audible.
Beauty Technology
BSEG's second platform is beauty technology. CEO Kimberley Kates and Director and CTO Dr. Bruce B. Lee have developed the company's first patent-pending beauty device — an advanced regenerative skincare device paired with a proprietary formula for the face and body. Dr. Lee previously created Acessa, acquired by Hologic for approximately $80 million in cash plus contingent payments.
BSEG is evaluating manufacturing, branding, licensing, and distribution, including a direct-to-consumer channel.
"This device represents years of work at the intersection of technology and regenerative skincare," said Dr. Bruce B. Lee. "We've combined an advanced device with a proprietary formula to deliver meaningful, visible results — with significant potential in the consumer market."
Strategic Combinations
Over the past year, BSEG has held discussions with multiple parties regarding potential mergers, strategic combinations, and other corporate transactions. Several continue under non-disclosure agreements.
"We built these relationships over twenty years, one film and one partner at a time," said Kates. "Now they are starting to compound — and we intend to make the most of every one of them."
